Review



ssbp1 rb  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Proteintech ssbp1 rb
    The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against <t>SSBP1</t> (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.
    Ssbp1 Rb, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/SSBP1+Antibody/pmc13009569-0-0-5
    Average 93 stars, based on 31 article reviews
    ssbp1 rb - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "mtDNA-Depleted Mitochondria Form Sites of Contact with the Nucleus and Alter the Cellular Epigenome"

    Article Title: mtDNA-Depleted Mitochondria Form Sites of Contact with the Nucleus and Alter the Cellular Epigenome

    Journal: Contact

    doi: 10.1177/25152564261428840

    The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against SSBP1 (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.
    Figure Legend Snippet: The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against SSBP1 (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.

    Techniques Used: Staining, Fluorescence

    Related Articles

    Immunohistochemistry:

    Article Title: The proteomic landscape of genotoxic stress-induced micronuclei.
    Article Snippet: SRSF1 (Thermo cat #324500); cGAS (Cell Signalling Technologies cat #15102S); 1:1000 53BP1 (Novus Biologicals cat #NB100—305SS); NUP107 (ThermoFisher cat #PA5-81528); Lamin A/C (Cell Signalling Technologies Molecular Cell 84, 1377–1391.e1–e6, April 4, 2024 e4 cat #4777T); Lamin B1 (Abcam cat #ab133741); Emerin (Abcam cat #ab204987); POLG (Thermo cat #21314); SSBP1 (Proteintech cat #12212); MGME1 (Proteintech cat #23178); CHCHD4 (Bethyl Laboratories cat #A305); CCDC77 (Abcam cat #ab91585); CEP63 (Thermo cat #TA809276S); ATRIP (Thermo cat #TA504642S); UBE2A (Bethyl Laboratories cat #A300); RPA1 (New England Biolabs cat #2267S); FEN1 (Bethyl Laboratories cat #IHC-00335-T); POLD1 (Bethyl Laboratories cat #A304-007A-T); RFC2 (Bethyl Laboratories cat #A300-142A-T); PQBP1 (Bethyl Laboratories cat #A302-801A-T); SRSF10 (Bethyl Laboratories cat #A302-282A-T); TRA2B (Bethyl Laboratories cat #A305-011A-T); TRA2A (Bethyl Laboratories cat #A303-779A-T); DDX5 (Bethyl Laboratories cat #A300523A-T). .. SRSF1 (Thermo cat #324500); cGAS (Cell Signalling Technologies cat #15102S); 1:1000 53BP1 (Novus Biologicals cat #NB100—305SS); NUP107 (ThermoFisher cat #PA5-81528); Lamin A/C (Cell Signalling Technologies Molecular Cell 84, 1377–1391.e1–e6, April 4, 2024 e4 cat #4777T); Lamin B1 (Abcam cat #ab133741); Emerin (Abcam cat #ab204987); POLG (Thermo cat #21314); SSBP1 (Proteintech cat #12212); MGME1 (Proteintech cat #23178); CHCHD4 (Bethyl Laboratories cat #A305); CCDC77 (Abcam cat #ab91585); CEP63 (Thermo cat #TA809276S); ATRIP (Thermo cat #TA504642S); UBE2A (Bethyl Laboratories cat #A300); RPA1 (New England Biolabs cat #2267S); FEN1 (Bethyl Laboratories cat #IHC-00335-T); POLD1 (Bethyl Laboratories cat #A304-007A-T); RFC2 (Bethyl Laboratories cat #A300-142A-T); PQBP1 (Bethyl Laboratories cat #A302-801A-T); SRSF10 (Bethyl Laboratories cat #A302-282A-T); TRA2B (Bethyl Laboratories cat #A305-011A-T); TRA2A (Bethyl Laboratories cat #A303-779A-T); DDX5 (Bethyl Laboratories cat #A300523A-T). .. The following dilutions were used for secondary antibodies: 1:500 AlexaFluor 568 Goat anti-rabbit IgG secondary (Invitrogen cat #A11036); 1:500 AlexaFluor 488 Goat anti-mouse IgG secondary (Invitrogen cat #A11001); 1:500 AlexaFluor 568 Goat anti-mouse IgG secondary (Invitrogen cat #A11004); 1:500 AlexaFluor 488 Goat anti-rabbit IgG secondary (Invitrogen cat #A11034); Cells were washed four times in PBS-T, then inverted onto a drop of Prolong Glass Antifade Mountant with NucBlue (DAPI) stain (Thermo Fisher Scientific, cat #P36981) on a microscope slide.

    other:

    Article Title: The proteomic landscape of genotoxic stress-induced micronuclei.
    Article Snippet: The following secondary antibodies were used for Immunoblots: Donkey Anti-Rabbit IgG AlexaFluor 790 (Jackson ImmunoResearch Labs cat #711-655-152), Donkey AntiMouse IgG AlexaFluor 680 (Jackson ImmunoResearch Labs cat #711-655-152).

    Western Blot:

    Article Title: The proteomic landscape of genotoxic stress-induced micronuclei.
    Article Snippet: Proteins were transferred from the gel to a nitrocellulose membrane (LI-COR Biosciences cat #926-31092). e5 Molecular Cell 84, 1377–1391.e1–e6, April 4, 2024 Membranes were blocked in 5% milk in PBS-T for 1 hour and incubated with primary antibody overnight at 4 C. Membranes were then washed 4 times in PBS-T and incubated for 1 hour at room temperature with fluorescently-conjugated secondary antibodies diluted 1:20,000. .. The following primary antibodies were used for immunoblots: 1:1000 NUP107 (ThermoFisher cat #PA5-81528); 1:1000 cGAS (Cell Signalling Technologies cat #15102S); 1:1000 GAPDH (New England Biolabs cat #97166S); 1:1000 Emerin (Abcam cat #ab204987); 1:500 POLG (ThermoFisher cat #PA5-21314); 1:500 MGME1 (Proteintech cat #23178-1-AP); 1:500 CHCHD4 (Bethyl Laboratories cat #A305-811A-T); 1:500 SSBP1 (Proteintech cat #12212-1-AP). .. The following secondary antibodies were used for Immunoblots: Donkey Anti-Rabbit IgG AlexaFluor 790 (Jackson ImmunoResearch Labs cat #711-655-152), Donkey AntiMouse IgG AlexaFluor 680 (Jackson ImmunoResearch Labs cat #711-655-152).

    Drug discovery:

    Article Title: Sanguinarine induces apoptosis in osteosarcoma by attenuating the binding of STAT3 to the single-stranded DNA-binding protein 1 (SSBP1) promoter region.
    Article Snippet: Funding information “Double First-Class” University Project, Grant/Award Number: CPU2018GF03; National Natural Science Foundation of China, Grant/Award Number: 81973524; Special Funds for Science and Technology Development under the Guidance of the Central Government, Grant/Award Numbers: 2021Szvup163, ZY20198020; Jiangsu Province Graduate Research and Practice Innovation Program, Grant/Award Number: KYCX20_0647 Abstract Background and Purpose: Osteosarcoma, a primary malignant bone tumour prevalent among adolescents and young adults, remains a considerable challenge despite protracted progress made in enhancing patient survival rates over the last 40 years.. Consequently, the development of novel therapeutic approaches for osteosarcoma is imperative.. Sanguinarine (SNG), a compound with demonstrated potent anticancer properties against various malignancies, presents a promising avenue for exploration.

    CCK-8 Assay:

    Article Title: Sanguinarine induces apoptosis in osteosarcoma by attenuating the binding of STAT3 to the single-stranded DNA-binding protein 1 (SSBP1) promoter region.
    Article Snippet: Funding information “Double First-Class” University Project, Grant/Award Number: CPU2018GF03; National Natural Science Foundation of China, Grant/Award Number: 81973524; Special Funds for Science and Technology Development under the Guidance of the Central Government, Grant/Award Numbers: 2021Szvup163, ZY20198020; Jiangsu Province Graduate Research and Practice Innovation Program, Grant/Award Number: KYCX20_0647 Abstract Background and Purpose: Osteosarcoma, a primary malignant bone tumour prevalent among adolescents and young adults, remains a considerable challenge despite protracted progress made in enhancing patient survival rates over the last 40 years.. Consequently, the development of novel therapeutic approaches for osteosarcoma is imperative.. Sanguinarine (SNG), a compound with demonstrated potent anticancer properties against various malignancies, presents a promising avenue for exploration.



    Similar Products

    ssbp1 rb  (Proteintech)
    93
    Proteintech ssbp1 rb
    The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against <t>SSBP1</t> (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.
    Ssbp1 Rb, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/SSBP1+Antibody/pmc13009569-0-0-5
    Average 93 stars, based on 1 article reviews
    ssbp1 rb - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    mesocricetus auratus ssbp1  (Yeasen Biotechnology)
    86
    Yeasen Biotechnology mesocricetus auratus ssbp1
    The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against <t>SSBP1</t> (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.
    Mesocricetus Auratus Ssbp1, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/auratus+mesocricetus+ssbp1/pm40848354-141-4-39
    Average 86 stars, based on 1 article reviews
    mesocricetus auratus ssbp1 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    proteintech 12212 1 ap  (Proteintech)
    93
    Proteintech proteintech 12212 1 ap
    The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against <t>SSBP1</t> (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.
    Proteintech 12212 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/SSBP1+Antibody/pm40921294-204-19-19
    Average 93 stars, based on 1 article reviews
    proteintech 12212 1 ap - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    α ssbp1  (Proteintech)
    93
    Proteintech α ssbp1
    The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against <t>SSBP1</t> (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.
    α Ssbp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/SSBP1+Antibody/pm40921294-204-18-19
    Average 93 stars, based on 1 article reviews
    α ssbp1 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    antibodies against ssbp1  (Proteintech)
    93
    Proteintech antibodies against ssbp1
    Integrated analysis of the expression of <t>SSBP1</t> in liver cancer. (A) Distribution of differential gene expression levels after mapping mitochondrial-located genes (MitoCarta3.0 list) onto the TCGA-LIHC dataset. (B) Enrichment analysis using the R language. The gene sets ranking at the top were predominantly implicated in mitochondrial organization and biogenesis. (C) mRNA levels of mitochondrial biogenesis genes (including ALAS1, SIRT3, TFAM, TFB2M, SSBP1, CYCS, POLRMT and POLG) in liver cancer and paracancerous tissue (n=5). (D) Expression profiles of POLG and SSBP1 in patients with liver cancer and corresponding controls derived from the GSE14520 (tumor, n=225; non-tumor, n=220) and GSE101685 datasets. (tumor, n=24; non-tumor, n=8). (E) Transcriptional expression levels of SSBP1 in the TCGA-LIHC dataset. (F) Association between SSBP1 expression and the prognosis of liver cancer in the overall population (n=364) using the Kaplan Meier Plotter online survival analysis tool. SSBP1, single-stranded DNA binding protein 1; TCGA-LIHC, The Cancer Genome Atlas liver hepatocellular carcinoma; ALAS1, aminolevulinic acid synthase 1; SIRT3, sirtuin 3; TFAM, transcription factor A, mitochondrial; TFB2M, transcription factor B2, mitochondrial; CYCS, cytochrome c, somatic; POLRMT, RNA polymerase mitochondrial; POLG, DNA polymerase γ; TPM, transcripts per million.
    Antibodies Against Ssbp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/SSBP1+Antibody/pmc12339803-84-21-39
    Average 93 stars, based on 1 article reviews
    antibodies against ssbp1 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    gene exp ssbp1 mm01131763 g1  (Thermo Fisher)
    94
    Thermo Fisher gene exp ssbp1 mm01131763 g1
    Integrated analysis of the expression of <t>SSBP1</t> in liver cancer. (A) Distribution of differential gene expression levels after mapping mitochondrial-located genes (MitoCarta3.0 list) onto the TCGA-LIHC dataset. (B) Enrichment analysis using the R language. The gene sets ranking at the top were predominantly implicated in mitochondrial organization and biogenesis. (C) mRNA levels of mitochondrial biogenesis genes (including ALAS1, SIRT3, TFAM, TFB2M, SSBP1, CYCS, POLRMT and POLG) in liver cancer and paracancerous tissue (n=5). (D) Expression profiles of POLG and SSBP1 in patients with liver cancer and corresponding controls derived from the GSE14520 (tumor, n=225; non-tumor, n=220) and GSE101685 datasets. (tumor, n=24; non-tumor, n=8). (E) Transcriptional expression levels of SSBP1 in the TCGA-LIHC dataset. (F) Association between SSBP1 expression and the prognosis of liver cancer in the overall population (n=364) using the Kaplan Meier Plotter online survival analysis tool. SSBP1, single-stranded DNA binding protein 1; TCGA-LIHC, The Cancer Genome Atlas liver hepatocellular carcinoma; ALAS1, aminolevulinic acid synthase 1; SIRT3, sirtuin 3; TFAM, transcription factor A, mitochondrial; TFB2M, transcription factor B2, mitochondrial; CYCS, cytochrome c, somatic; POLRMT, RNA polymerase mitochondrial; POLG, DNA polymerase γ; TPM, transcripts per million.
    Gene Exp Ssbp1 Mm01131763 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/Gene+Exp%2E+Ssbp1%2C+Mm01131763_g1/pm40246179-110-48-19
    Average 94 stars, based on 1 article reviews
    gene exp ssbp1 mm01131763 g1 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    mitochondrial marker ssbp1  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mitochondrial marker ssbp1
    Integrated analysis of the expression of <t>SSBP1</t> in liver cancer. (A) Distribution of differential gene expression levels after mapping mitochondrial-located genes (MitoCarta3.0 list) onto the TCGA-LIHC dataset. (B) Enrichment analysis using the R language. The gene sets ranking at the top were predominantly implicated in mitochondrial organization and biogenesis. (C) mRNA levels of mitochondrial biogenesis genes (including ALAS1, SIRT3, TFAM, TFB2M, SSBP1, CYCS, POLRMT and POLG) in liver cancer and paracancerous tissue (n=5). (D) Expression profiles of POLG and SSBP1 in patients with liver cancer and corresponding controls derived from the GSE14520 (tumor, n=225; non-tumor, n=220) and GSE101685 datasets. (tumor, n=24; non-tumor, n=8). (E) Transcriptional expression levels of SSBP1 in the TCGA-LIHC dataset. (F) Association between SSBP1 expression and the prognosis of liver cancer in the overall population (n=364) using the Kaplan Meier Plotter online survival analysis tool. SSBP1, single-stranded DNA binding protein 1; TCGA-LIHC, The Cancer Genome Atlas liver hepatocellular carcinoma; ALAS1, aminolevulinic acid synthase 1; SIRT3, sirtuin 3; TFAM, transcription factor A, mitochondrial; TFB2M, transcription factor B2, mitochondrial; CYCS, cytochrome c, somatic; POLRMT, RNA polymerase mitochondrial; POLG, DNA polymerase γ; TPM, transcripts per million.
    Mitochondrial Marker Ssbp1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/SSBP1+Antibody/pm39994734-61-26-29
    Average 93 stars, based on 1 article reviews
    mitochondrial marker ssbp1 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    12212 1 ap  (Proteintech)
    93
    Proteintech 12212 1 ap
    Integrated analysis of the expression of <t>SSBP1</t> in liver cancer. (A) Distribution of differential gene expression levels after mapping mitochondrial-located genes (MitoCarta3.0 list) onto the TCGA-LIHC dataset. (B) Enrichment analysis using the R language. The gene sets ranking at the top were predominantly implicated in mitochondrial organization and biogenesis. (C) mRNA levels of mitochondrial biogenesis genes (including ALAS1, SIRT3, TFAM, TFB2M, SSBP1, CYCS, POLRMT and POLG) in liver cancer and paracancerous tissue (n=5). (D) Expression profiles of POLG and SSBP1 in patients with liver cancer and corresponding controls derived from the GSE14520 (tumor, n=225; non-tumor, n=220) and GSE101685 datasets. (tumor, n=24; non-tumor, n=8). (E) Transcriptional expression levels of SSBP1 in the TCGA-LIHC dataset. (F) Association between SSBP1 expression and the prognosis of liver cancer in the overall population (n=364) using the Kaplan Meier Plotter online survival analysis tool. SSBP1, single-stranded DNA binding protein 1; TCGA-LIHC, The Cancer Genome Atlas liver hepatocellular carcinoma; ALAS1, aminolevulinic acid synthase 1; SIRT3, sirtuin 3; TFAM, transcription factor A, mitochondrial; TFB2M, transcription factor B2, mitochondrial; CYCS, cytochrome c, somatic; POLRMT, RNA polymerase mitochondrial; POLG, DNA polymerase γ; TPM, transcripts per million.
    12212 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ssbp1/SSBP1+Antibody/pm39643024-87-15-10
    Average 93 stars, based on 1 article reviews
    12212 1 ap - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against SSBP1 (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.

    Journal: Contact

    Article Title: mtDNA-Depleted Mitochondria Form Sites of Contact with the Nucleus and Alter the Cellular Epigenome

    doi: 10.1177/25152564261428840

    Figure Lengend Snippet: The number of mitochondrial sites of contact with the nucleus is greater in cells devoid of mtDNA. (A) Representative images obtained in 4T1 Wildtype (left) and ρ 0 (right) cells, immunolabelled against SSBP1 (green) and Anti-DNA (red). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (B) Quantification of SSBP1 mean intensity normalised to background fluorescence (4T1: 42.28 ± 7.016; ρ 0 : 0.5512 ± 2.188) (C) Representative images obtained in Wildtype (left) and ρ 0 (right) cells, immunolabelled against MT-CO1 (green). Nuclei were stained with DAPI (blue); Scale bar = 10 µM. (D) Quantification of MT-CO1 mean intensity normalised to background fluorescence (4T1:47.7 ± 6.4; ρ 0 : 0.99 ± 0.94); n = 10. (E) Visual representation of normal mitochondrial distribution (i) and mitochondrial redistribution leading to contact formation (ii). (F) Representative TEM images of mitochondria (red), which are in relative proximity of the nucleus (cyan), circles indicate sites of contact between a mitochondrion and the nucleus, scale bar = 500 nm (G) Quantification of mean number of contact sites per cell (4T1:0.12 ± 0.08; ρ 0 : 0.79 ± 0.21). (H) Quantification of mean cell area (4T1:30776 ± 10,357; ρ 0 : 22,874 ± 10,173). (I) Quantification of mean nucleus area (4T1: 11,270 ± 5185; ρ 0 : 7538 ± 5407). * = P ≤ 0.05, ** = P ≤ 0.01, n = 20.

    Article Snippet: SSBP1 (Rb) , 1:400 , proteintech, 12212-1-AP.

    Techniques: Staining, Fluorescence

    Integrated analysis of the expression of SSBP1 in liver cancer. (A) Distribution of differential gene expression levels after mapping mitochondrial-located genes (MitoCarta3.0 list) onto the TCGA-LIHC dataset. (B) Enrichment analysis using the R language. The gene sets ranking at the top were predominantly implicated in mitochondrial organization and biogenesis. (C) mRNA levels of mitochondrial biogenesis genes (including ALAS1, SIRT3, TFAM, TFB2M, SSBP1, CYCS, POLRMT and POLG) in liver cancer and paracancerous tissue (n=5). (D) Expression profiles of POLG and SSBP1 in patients with liver cancer and corresponding controls derived from the GSE14520 (tumor, n=225; non-tumor, n=220) and GSE101685 datasets. (tumor, n=24; non-tumor, n=8). (E) Transcriptional expression levels of SSBP1 in the TCGA-LIHC dataset. (F) Association between SSBP1 expression and the prognosis of liver cancer in the overall population (n=364) using the Kaplan Meier Plotter online survival analysis tool. SSBP1, single-stranded DNA binding protein 1; TCGA-LIHC, The Cancer Genome Atlas liver hepatocellular carcinoma; ALAS1, aminolevulinic acid synthase 1; SIRT3, sirtuin 3; TFAM, transcription factor A, mitochondrial; TFB2M, transcription factor B2, mitochondrial; CYCS, cytochrome c, somatic; POLRMT, RNA polymerase mitochondrial; POLG, DNA polymerase γ; TPM, transcripts per million.

    Journal: International Journal of Oncology

    Article Title: Inhibiting SSBP1 enhances ferroptosis and improves the effectiveness of sorafenib treatment for liver cancer

    doi: 10.3892/ijo.2025.5778

    Figure Lengend Snippet: Integrated analysis of the expression of SSBP1 in liver cancer. (A) Distribution of differential gene expression levels after mapping mitochondrial-located genes (MitoCarta3.0 list) onto the TCGA-LIHC dataset. (B) Enrichment analysis using the R language. The gene sets ranking at the top were predominantly implicated in mitochondrial organization and biogenesis. (C) mRNA levels of mitochondrial biogenesis genes (including ALAS1, SIRT3, TFAM, TFB2M, SSBP1, CYCS, POLRMT and POLG) in liver cancer and paracancerous tissue (n=5). (D) Expression profiles of POLG and SSBP1 in patients with liver cancer and corresponding controls derived from the GSE14520 (tumor, n=225; non-tumor, n=220) and GSE101685 datasets. (tumor, n=24; non-tumor, n=8). (E) Transcriptional expression levels of SSBP1 in the TCGA-LIHC dataset. (F) Association between SSBP1 expression and the prognosis of liver cancer in the overall population (n=364) using the Kaplan Meier Plotter online survival analysis tool. SSBP1, single-stranded DNA binding protein 1; TCGA-LIHC, The Cancer Genome Atlas liver hepatocellular carcinoma; ALAS1, aminolevulinic acid synthase 1; SIRT3, sirtuin 3; TFAM, transcription factor A, mitochondrial; TFB2M, transcription factor B2, mitochondrial; CYCS, cytochrome c, somatic; POLRMT, RNA polymerase mitochondrial; POLG, DNA polymerase γ; TPM, transcripts per million.

    Article Snippet: Following blocking with 10% skimmed milk powder solution for 2 h at room temperature, the PVDF membrane was incubated with primary antibodies against SSBP1 (anti-rabbit; cat. no. 12212-1-AP), voltage-dependent anion channel (VDAC; anti-rabbit; cat. no. 10866-1-AP; both 1:1,000; both Proteintech Group, Inc.), Flag (anti-mouse; cat. no. F1804; Merck KGaA; 1:10,000), translocase of the outer mitochondrial membrane 20 (TOM20; anti-rabbit; cat. no. A19403; 1:5,000), glutathione peroxidase 4 (GPX4; anti-rabbit; cat. no. A11243), SLC7A11 (anti-rabbit; cat. no. A13685; both 1:1,000), and β-actin (anti-rabbit; cat. no. AC026; 1:100,000; all from ABclonal Biotech Co., Ltd.) at 4°C overnight.

    Techniques: Expressing, Gene Expression, Derivative Assay, Binding Assay

    Knockout of SSBP1 in Hep3B cells inhibits the proliferation and migratory capacity of liver cancer cells. (A) SSBP1 expression in control and SSBP1-KO Hep3B cells. (B) MTT assay showed the relative viability of control and SSBP1-KO Hep3B cells (n=10). (C) Representative colony formation plots showing the proliferation capacity of Hep3B cells with SSBP1 KO. (D) Colony formation capacity (n=4). (E) Migratory capacity of control and SSBP1-KO Hep3B cells was examined by Transwell assay. (F) Wound healing assay was used to determine the migratory capacity of Hep3B cells with SSBP1 deficiency. Scale bar, 200 μ m. Magnification, ×40. SSBP1, single-stranded DNA binding protein 1; SSBP1-KO, (single-stranded DNA binding protein 1) knockout.

    Journal: International Journal of Oncology

    Article Title: Inhibiting SSBP1 enhances ferroptosis and improves the effectiveness of sorafenib treatment for liver cancer

    doi: 10.3892/ijo.2025.5778

    Figure Lengend Snippet: Knockout of SSBP1 in Hep3B cells inhibits the proliferation and migratory capacity of liver cancer cells. (A) SSBP1 expression in control and SSBP1-KO Hep3B cells. (B) MTT assay showed the relative viability of control and SSBP1-KO Hep3B cells (n=10). (C) Representative colony formation plots showing the proliferation capacity of Hep3B cells with SSBP1 KO. (D) Colony formation capacity (n=4). (E) Migratory capacity of control and SSBP1-KO Hep3B cells was examined by Transwell assay. (F) Wound healing assay was used to determine the migratory capacity of Hep3B cells with SSBP1 deficiency. Scale bar, 200 μ m. Magnification, ×40. SSBP1, single-stranded DNA binding protein 1; SSBP1-KO, (single-stranded DNA binding protein 1) knockout.

    Article Snippet: Following blocking with 10% skimmed milk powder solution for 2 h at room temperature, the PVDF membrane was incubated with primary antibodies against SSBP1 (anti-rabbit; cat. no. 12212-1-AP), voltage-dependent anion channel (VDAC; anti-rabbit; cat. no. 10866-1-AP; both 1:1,000; both Proteintech Group, Inc.), Flag (anti-mouse; cat. no. F1804; Merck KGaA; 1:10,000), translocase of the outer mitochondrial membrane 20 (TOM20; anti-rabbit; cat. no. A19403; 1:5,000), glutathione peroxidase 4 (GPX4; anti-rabbit; cat. no. A11243), SLC7A11 (anti-rabbit; cat. no. A13685; both 1:1,000), and β-actin (anti-rabbit; cat. no. AC026; 1:100,000; all from ABclonal Biotech Co., Ltd.) at 4°C overnight.

    Techniques: Knock-Out, Expressing, Control, MTT Assay, Transwell Assay, Wound Healing Assay, Binding Assay

    SSBP1-OE enhances proliferation and migratory capacity of liver cancer cells. (A) Representative bands of control and SSBP1-OE Hep3B cells to validate the effect by Western blotting. Flag signals represent fusion proteins detected by anti-Flag antibody. Control vector-transfected cells were used as negative controls to confirm specific expression of the fusion protein. (B) Viability of control and SSBP1-OE Hep3B cells (n=10). (C) Representative colony formation plots showing the proliferation capacity of Hep3B cells with SSBP1 OE. (D) Colony formation capacity (n=4). (E) Migratory capacity of control and SSBP1-OE Hep3B cells was examined by Transwell assay. (F) Wound healing assay was used to determine the migratory capacity of Hep3B cells with SSBP1 OE. Scale bar, 200 μ m. Magnification, ×40. SSBP1-OE, (single-stranded DNA binding protein 1) overexpression.

    Journal: International Journal of Oncology

    Article Title: Inhibiting SSBP1 enhances ferroptosis and improves the effectiveness of sorafenib treatment for liver cancer

    doi: 10.3892/ijo.2025.5778

    Figure Lengend Snippet: SSBP1-OE enhances proliferation and migratory capacity of liver cancer cells. (A) Representative bands of control and SSBP1-OE Hep3B cells to validate the effect by Western blotting. Flag signals represent fusion proteins detected by anti-Flag antibody. Control vector-transfected cells were used as negative controls to confirm specific expression of the fusion protein. (B) Viability of control and SSBP1-OE Hep3B cells (n=10). (C) Representative colony formation plots showing the proliferation capacity of Hep3B cells with SSBP1 OE. (D) Colony formation capacity (n=4). (E) Migratory capacity of control and SSBP1-OE Hep3B cells was examined by Transwell assay. (F) Wound healing assay was used to determine the migratory capacity of Hep3B cells with SSBP1 OE. Scale bar, 200 μ m. Magnification, ×40. SSBP1-OE, (single-stranded DNA binding protein 1) overexpression.

    Article Snippet: Following blocking with 10% skimmed milk powder solution for 2 h at room temperature, the PVDF membrane was incubated with primary antibodies against SSBP1 (anti-rabbit; cat. no. 12212-1-AP), voltage-dependent anion channel (VDAC; anti-rabbit; cat. no. 10866-1-AP; both 1:1,000; both Proteintech Group, Inc.), Flag (anti-mouse; cat. no. F1804; Merck KGaA; 1:10,000), translocase of the outer mitochondrial membrane 20 (TOM20; anti-rabbit; cat. no. A19403; 1:5,000), glutathione peroxidase 4 (GPX4; anti-rabbit; cat. no. A11243), SLC7A11 (anti-rabbit; cat. no. A13685; both 1:1,000), and β-actin (anti-rabbit; cat. no. AC026; 1:100,000; all from ABclonal Biotech Co., Ltd.) at 4°C overnight.

    Techniques: Control, Western Blot, Plasmid Preparation, Transfection, Expressing, Transwell Assay, Wound Healing Assay, Binding Assay, Over Expression

    SSBP1 deficiency inhibits mitochondrial function. (A) qPCR was used to analyze the mtDNA copy number of liver cancer and paracancerous tissue (n=6). (B) Immunofluorescence was performed to detect the mitochondrial morphology in Hep3B cells following SSBP1 KO. Scale bar, 10 μ m. Magnification, ×630. (C) Flow cytometry was employed to analyze the mitochondrial mass of control and SSBP1-KO Hep3B cells (n=6-7). (D) qPCR was used to analyze the mtDNA copy number of control and SSBP1-KO Hep3B cells (n=7). (E) Expression of mitochondrial proteins in control and SSBP1-KO Hep3B cells. (F) Flow cytometry was employed to analyze (G) levels of ROS of control and SSBP1-KO Hep3B cells (n=9). (H) Flow cytometry was applied to analyze (I) MMP of control and SSBP1-KO Hep3B cells (n=3). q, Quantitative; KO, SSBP1 (single-stranded DNA binding protein 1) knockout; mtDNA, mitochondrial DNA; VDAC, Voltage-Dependent Anion Channel; TOM20, Translocase of the Outer Mitochondrial Membrane 20; ROS, Reactive Oxygen Species.

    Journal: International Journal of Oncology

    Article Title: Inhibiting SSBP1 enhances ferroptosis and improves the effectiveness of sorafenib treatment for liver cancer

    doi: 10.3892/ijo.2025.5778

    Figure Lengend Snippet: SSBP1 deficiency inhibits mitochondrial function. (A) qPCR was used to analyze the mtDNA copy number of liver cancer and paracancerous tissue (n=6). (B) Immunofluorescence was performed to detect the mitochondrial morphology in Hep3B cells following SSBP1 KO. Scale bar, 10 μ m. Magnification, ×630. (C) Flow cytometry was employed to analyze the mitochondrial mass of control and SSBP1-KO Hep3B cells (n=6-7). (D) qPCR was used to analyze the mtDNA copy number of control and SSBP1-KO Hep3B cells (n=7). (E) Expression of mitochondrial proteins in control and SSBP1-KO Hep3B cells. (F) Flow cytometry was employed to analyze (G) levels of ROS of control and SSBP1-KO Hep3B cells (n=9). (H) Flow cytometry was applied to analyze (I) MMP of control and SSBP1-KO Hep3B cells (n=3). q, Quantitative; KO, SSBP1 (single-stranded DNA binding protein 1) knockout; mtDNA, mitochondrial DNA; VDAC, Voltage-Dependent Anion Channel; TOM20, Translocase of the Outer Mitochondrial Membrane 20; ROS, Reactive Oxygen Species.

    Article Snippet: Following blocking with 10% skimmed milk powder solution for 2 h at room temperature, the PVDF membrane was incubated with primary antibodies against SSBP1 (anti-rabbit; cat. no. 12212-1-AP), voltage-dependent anion channel (VDAC; anti-rabbit; cat. no. 10866-1-AP; both 1:1,000; both Proteintech Group, Inc.), Flag (anti-mouse; cat. no. F1804; Merck KGaA; 1:10,000), translocase of the outer mitochondrial membrane 20 (TOM20; anti-rabbit; cat. no. A19403; 1:5,000), glutathione peroxidase 4 (GPX4; anti-rabbit; cat. no. A11243), SLC7A11 (anti-rabbit; cat. no. A13685; both 1:1,000), and β-actin (anti-rabbit; cat. no. AC026; 1:100,000; all from ABclonal Biotech Co., Ltd.) at 4°C overnight.

    Techniques: Immunofluorescence, Flow Cytometry, Control, Expressing, Binding Assay, Knock-Out, Membrane

    SSBP1 deficiency triggers ferroptosis in liver cancer cells. (A) Flow cytometry was performed to analyze (B) relative death level (PI + ) in control and SSBP1 -KO Hep3B cells (n=8-10). (C) Flow cytometry was applied to analyze (D) C11-BODIPY levels of control and SSBP1 -KO Hep3B cells (n=8). (E) Fluorescence images of C11-BODIPY-stained Hep3B cells. (F) Relative fluorescence intensity (n=3). Scale bar, 20 μ m. Magnification, ×200. (G) Western blotting of ferroptosis-associated proteins in Control and SSBP1-KO Hep3B cells. (H) mRNA expression of ferroptosis-associated genes in Control and SSBP1-KO Hep3B cells (n=6). SSBP1-KO, SSBP1 (single-stranded DNA binding protein 1) knockout; C11-BODIPY, 11-carbon-substituted boron dipyrromethene; GPX4, glutathione peroxidase 4; SLC7A11, solute carrier family 7 member 11; ME1, malic enzyme 1.

    Journal: International Journal of Oncology

    Article Title: Inhibiting SSBP1 enhances ferroptosis and improves the effectiveness of sorafenib treatment for liver cancer

    doi: 10.3892/ijo.2025.5778

    Figure Lengend Snippet: SSBP1 deficiency triggers ferroptosis in liver cancer cells. (A) Flow cytometry was performed to analyze (B) relative death level (PI + ) in control and SSBP1 -KO Hep3B cells (n=8-10). (C) Flow cytometry was applied to analyze (D) C11-BODIPY levels of control and SSBP1 -KO Hep3B cells (n=8). (E) Fluorescence images of C11-BODIPY-stained Hep3B cells. (F) Relative fluorescence intensity (n=3). Scale bar, 20 μ m. Magnification, ×200. (G) Western blotting of ferroptosis-associated proteins in Control and SSBP1-KO Hep3B cells. (H) mRNA expression of ferroptosis-associated genes in Control and SSBP1-KO Hep3B cells (n=6). SSBP1-KO, SSBP1 (single-stranded DNA binding protein 1) knockout; C11-BODIPY, 11-carbon-substituted boron dipyrromethene; GPX4, glutathione peroxidase 4; SLC7A11, solute carrier family 7 member 11; ME1, malic enzyme 1.

    Article Snippet: Following blocking with 10% skimmed milk powder solution for 2 h at room temperature, the PVDF membrane was incubated with primary antibodies against SSBP1 (anti-rabbit; cat. no. 12212-1-AP), voltage-dependent anion channel (VDAC; anti-rabbit; cat. no. 10866-1-AP; both 1:1,000; both Proteintech Group, Inc.), Flag (anti-mouse; cat. no. F1804; Merck KGaA; 1:10,000), translocase of the outer mitochondrial membrane 20 (TOM20; anti-rabbit; cat. no. A19403; 1:5,000), glutathione peroxidase 4 (GPX4; anti-rabbit; cat. no. A11243), SLC7A11 (anti-rabbit; cat. no. A13685; both 1:1,000), and β-actin (anti-rabbit; cat. no. AC026; 1:100,000; all from ABclonal Biotech Co., Ltd.) at 4°C overnight.

    Techniques: Flow Cytometry, Control, Fluorescence, Staining, Western Blot, Expressing, Binding Assay, Knock-Out

    SSBP1 deficiency enhances the effect of sora treatment. (A) Expression of SSBP1, TOM20 and GPX4 in Con and SSBP1-KO Hep3B cells with or without sora treatment. (B) MTT assay showed the relative viability of Con and SSBP1-KO Hep3B cells with or without sora treatment (n=6). (C) Representative colony formation assay showing proliferation capacity of Hep3B cells with SSBP1 KO in the presence or absence of sora treatment. (D) Colony formation capacity (n=3). (E) Immunofluorescence was performed to detect the mitochondrial morphology in Hep3B cells following SSBP1 KO in the presence or absence of sora. Scale bar, 5 μ m. Magnification, ×630. (F) qPCR was used to analyze the mtDNA copy number of Con and SSBP1-KO Hep3B cells with or without sora treatment (n=4-5). Flow cytometry was employed to analyze (G) mitochondrial mass (n=3-4) and (H) ROS levels (n=4-5) of Con and SSBP1-KO Hep3B cells with or without sora treatment. (I) ROS levels in Con and SSBP1-KO Hep3B cells with or without sora (n=4-5). (J) Flow cytometry was performed to analyze (K) MMP of Control and SSBP1-KO Hep3B cells with or without sora (n=3-4). (L) Fluorescence images of C11-BODIPY-stained Hep3B cells. (M) Relative fluorescence intensity was quantified by ImageJ software (n=3). Scale bar, 20 μ m. Magnification, ×200. (N) mRNA expression of ferroptosis-associated gene GPX4 in Con and SSBP1-KO Hep3B cells in the presence or absence of sora (n=6). TOM20, translocase of the outer mitochondrial membrane 20; GPX4, glutathione peroxidase 4; SSBP1-KO, SSBP1 (single-stranded DNA binding protein 1) knockout; mtDNA, mitochondrial DNA; Con, control; sora, sorafenib.

    Journal: International Journal of Oncology

    Article Title: Inhibiting SSBP1 enhances ferroptosis and improves the effectiveness of sorafenib treatment for liver cancer

    doi: 10.3892/ijo.2025.5778

    Figure Lengend Snippet: SSBP1 deficiency enhances the effect of sora treatment. (A) Expression of SSBP1, TOM20 and GPX4 in Con and SSBP1-KO Hep3B cells with or without sora treatment. (B) MTT assay showed the relative viability of Con and SSBP1-KO Hep3B cells with or without sora treatment (n=6). (C) Representative colony formation assay showing proliferation capacity of Hep3B cells with SSBP1 KO in the presence or absence of sora treatment. (D) Colony formation capacity (n=3). (E) Immunofluorescence was performed to detect the mitochondrial morphology in Hep3B cells following SSBP1 KO in the presence or absence of sora. Scale bar, 5 μ m. Magnification, ×630. (F) qPCR was used to analyze the mtDNA copy number of Con and SSBP1-KO Hep3B cells with or without sora treatment (n=4-5). Flow cytometry was employed to analyze (G) mitochondrial mass (n=3-4) and (H) ROS levels (n=4-5) of Con and SSBP1-KO Hep3B cells with or without sora treatment. (I) ROS levels in Con and SSBP1-KO Hep3B cells with or without sora (n=4-5). (J) Flow cytometry was performed to analyze (K) MMP of Control and SSBP1-KO Hep3B cells with or without sora (n=3-4). (L) Fluorescence images of C11-BODIPY-stained Hep3B cells. (M) Relative fluorescence intensity was quantified by ImageJ software (n=3). Scale bar, 20 μ m. Magnification, ×200. (N) mRNA expression of ferroptosis-associated gene GPX4 in Con and SSBP1-KO Hep3B cells in the presence or absence of sora (n=6). TOM20, translocase of the outer mitochondrial membrane 20; GPX4, glutathione peroxidase 4; SSBP1-KO, SSBP1 (single-stranded DNA binding protein 1) knockout; mtDNA, mitochondrial DNA; Con, control; sora, sorafenib.

    Article Snippet: Following blocking with 10% skimmed milk powder solution for 2 h at room temperature, the PVDF membrane was incubated with primary antibodies against SSBP1 (anti-rabbit; cat. no. 12212-1-AP), voltage-dependent anion channel (VDAC; anti-rabbit; cat. no. 10866-1-AP; both 1:1,000; both Proteintech Group, Inc.), Flag (anti-mouse; cat. no. F1804; Merck KGaA; 1:10,000), translocase of the outer mitochondrial membrane 20 (TOM20; anti-rabbit; cat. no. A19403; 1:5,000), glutathione peroxidase 4 (GPX4; anti-rabbit; cat. no. A11243), SLC7A11 (anti-rabbit; cat. no. A13685; both 1:1,000), and β-actin (anti-rabbit; cat. no. AC026; 1:100,000; all from ABclonal Biotech Co., Ltd.) at 4°C overnight.

    Techniques: Expressing, MTT Assay, Colony Assay, Immunofluorescence, Flow Cytometry, Control, Fluorescence, Staining, Software, Membrane, Binding Assay, Knock-Out

    SSBP1 deficiency enhances liver cancer cell sensitivity to sorafenib. SSBP1 deficiency impairs mitochondrial function and exacerbates lipid peroxidation in liver cancer cells, sensitizing them to sorafenib-induced ferroptosis. SSBP1-KO-driven mitochondrial dysfunction and cytosolic/mitochondrial lipid peroxide accumulation leads to diminished GPX4 and SLC7A11 activity. These alterations amplify ferroptosis under sorafenib treatment, underscoring SSBP1 loss as a key determinant of sorafenib sensitivity in liver cancer by disrupting redox homeostasis and mitochondrial integrity. MMP, mitochondrial membrane potential; SSBP1-KO, single-stranded DNA binding protein 1-knockout; GPX4, glutathione peroxidase 4; SLC7A11, solute carrier family 7 member 11; WT, wildtype.

    Journal: International Journal of Oncology

    Article Title: Inhibiting SSBP1 enhances ferroptosis and improves the effectiveness of sorafenib treatment for liver cancer

    doi: 10.3892/ijo.2025.5778

    Figure Lengend Snippet: SSBP1 deficiency enhances liver cancer cell sensitivity to sorafenib. SSBP1 deficiency impairs mitochondrial function and exacerbates lipid peroxidation in liver cancer cells, sensitizing them to sorafenib-induced ferroptosis. SSBP1-KO-driven mitochondrial dysfunction and cytosolic/mitochondrial lipid peroxide accumulation leads to diminished GPX4 and SLC7A11 activity. These alterations amplify ferroptosis under sorafenib treatment, underscoring SSBP1 loss as a key determinant of sorafenib sensitivity in liver cancer by disrupting redox homeostasis and mitochondrial integrity. MMP, mitochondrial membrane potential; SSBP1-KO, single-stranded DNA binding protein 1-knockout; GPX4, glutathione peroxidase 4; SLC7A11, solute carrier family 7 member 11; WT, wildtype.

    Article Snippet: Following blocking with 10% skimmed milk powder solution for 2 h at room temperature, the PVDF membrane was incubated with primary antibodies against SSBP1 (anti-rabbit; cat. no. 12212-1-AP), voltage-dependent anion channel (VDAC; anti-rabbit; cat. no. 10866-1-AP; both 1:1,000; both Proteintech Group, Inc.), Flag (anti-mouse; cat. no. F1804; Merck KGaA; 1:10,000), translocase of the outer mitochondrial membrane 20 (TOM20; anti-rabbit; cat. no. A19403; 1:5,000), glutathione peroxidase 4 (GPX4; anti-rabbit; cat. no. A11243), SLC7A11 (anti-rabbit; cat. no. A13685; both 1:1,000), and β-actin (anti-rabbit; cat. no. AC026; 1:100,000; all from ABclonal Biotech Co., Ltd.) at 4°C overnight.

    Techniques: Activity Assay, Membrane, Binding Assay, Knock-Out